2,689
Views
1
CrossRef citations to date
0
Altmetric
Reviews

CAPTURE ALS: the comprehensive analysis platform to understand, remedy and eliminate ALS

ORCID Icon, , , , , , , , , , , , , , , , , , , , , & show all
Pages 33-39 | Received 19 Nov 2021, Accepted 08 Feb 2022, Published online: 23 Feb 2022

References

  • Fournier C, Glass JD. Modeling the course of amyotrophic lateral sclerosis. Nat Biotechnol. 2015;33:45–7.
  • Kalra S, Khan MU, Barlow L, Beaulieu C, Benatar M, Briemberg H, et al. The Canadian ALS Neuroimaging Consortium (CALSNIC) – A multicentre platform for standardized imaging and clinical studies in ALS [Internet]. medRxiv. medRxiv; 2020. p. 2020.07.10.20142679.
  • Ta D, Khan M, Ishaque A, Seres P, Eurich D, Yang YH, et al. Reliability of 3D texture analysis: a multicenter MRI study of the brain. J Magn Reson Imaging. 2020;51:1200–9.
  • Kalra S, Müller HP, Ishaque A, Zinman L, Korngut L, Genge A, et al. A prospective harmonized multicenter DTI study of cerebral white matter degeneration in ALS. Neurology. 2020;95:e943–e952.
  • Bharti K, Khan M, Beaulieu C, Graham SJ, Briemberg H, Frayne R, et al. Involvement of the dentate nucleus in the pathophysiology of amyotrophic lateral sclerosis: a multi-center and multi-modal neuroimaging study. NeuroImage Clin. 2020; 28: 102385
  • Chenji S, Ishaque A, Mah D, Fujiwara E, Beaulieu C, Seres P, et al. Neuroanatomical associations of the Edinburgh cognitive and Behavioural ALS screen (ECAS). Brain Imaging Behav. 2021 Jun;15(3):1641–1654.
  • Ta D, Ishaque A, Srivastava O, Hanstock C, Seres P, Eurich DT, et al. Progressive neurochemical abnormalities in cognitive and motor subgroups of amyotrophic lateral sclerosis: a prospective multicenter study. Neurology. 2021;97:e803–13–e813.
  • Ishaque A, Ta D, Khan M, Zinman L, Korngut L, Genge A, et al. Distinct patterns of progressive gray and white matter degeneration in amyotrophic lateral sclerosis. Hum Brain Mapp 2021.
  • Das S, Glatard T, Rogers C, Saigle J, Paiva S, Macintyre L, et al. Cyber infrastructure for open science at the Montreal neurological institute. Front Neuroinform. 2017; Jan 6;10:53
  • Das S, Abou-Haidar R, Rabalais H, Sun SDLW, Rosli Z, Chatpar K, et al. The C-BIG repository: an institution-level open science platform. Neuroinform. 2021.
  • Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:9–14.
  • Niven E, Newton J, Foley J, Colville S, Swingler R, Chandran S, et al. Validation of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): a cognitive tool for motor disorders. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:172–9.
  • Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.
  • Srivastava O, Hanstock C, Chenji S, Mah D, Eurich D, Ta D, et al. Cerebral degeneration in amyotrophic lateral sclerosis: a prospective multicenter magnetic resonance spectroscopy study. Neurol Clin Pract. 2019;9:400–7.
  • E Elahi GMM, Kalra S, Zinman L, Genge A, Korngut L, Yang YH. Texture classification of MR images of the brain in ALS using M-CoHOG: a multi-center study. Comput Med Imaging Graph 2020. Jan;79:101659
  • Jadoul Y, Thompson B, de Boer B. Introducing Parselmouth: a Python interface to Praat. J Phon. 2018;71:1–15.
  • Yunusova Y, Graham NL, Shellikeri S, Phuong K, Kulkarni M, Rochon E, et al. Profiling speech and pausing in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). PLOS One. 2016;11:e0147573.
  • Yunusova Y, Green JR, Wang J, Pattee G, Zinman L. A protocol for comprehensive assessment of bulbar dysfunction in amyotrophic lateral sclerosis (ALS). J Vis Exp. 2011. Feb 21;(48):2422.
  • Barnett C, Green JR, Marzouqah R, Stipancic KL, Berry JD, Korngut L, et al. Reliability and validity of speech & pause measures during passage reading in ALS. Amyotroph Lateral Scler Front Degener. 2020; Feb;21(1-2):42-50
  • Wang J, Kothalkar PV, Kim M, Yunusova Y, Campbell TF, Heitzman D, et al. Predicting intelligible speaking rate in individuals with amyotrophic lateral sclerosis from a small number of speech acoustic and articulatory samples. 2016. Sep;2016:91-97
  • Rong P, Yunusova Y, Wang J, Green JR. Predicting early bulbar decline in amyotrophic lateral sclerosis: a speech subsystem approach. Behav Neurol. 2015;2015:183027.
  • Alas JK, Godlovitch G, Mohan CM, Jelinski SA, Khan AA. Regulatory Framework for Conducting Clinical Research in Canada. Can J Neurol Sci Le J Can des Sci Neurol. 2017 Sep;44(5):469–74.
  • Johnson SB, Whitney G, McAuliffe M, Wang H, McCreedy E, Rozenblit L, et al. Using global unique identifiers to link autism collections. J Am Med Informatics Assoc. 2010. Nov-Dec 2010;17(6):689–95.
  • Das S, Zijdenbos AP, Harlap J, Vins D, Evans AC. LORIS: a web-based data management system for multi-center studies. Front Neuroinform 2012Jan 20;5:37
  • Das S, Lecours Boucher X, Rogers C, Makowski C, Chouinard-Decorte F, Oros Klein K, et al. Integration of “omics” data and phenotypic data within a unified extensible multimodal framework. Front Neuroinform 2018. Dec 18;12:91
  • Mohaddes Z, Das S, Abou-Haidar R, Safi-Harab M, Blader D, Callegaro J, et al. National neuroinformatics framework for Canadian Consortium on Neurodegeneration in Aging (CCNA). Front Neuroinform 2018;12:85.
  • Caspers S, Moebus S, Lux S, Pundt N, Schütz H, Mühleisen TW, et al. Studying variability in human brain aging in a population-based German cohort-rationale and design of 1000BRAINS. Front Aging Neurosci 2014;6:149.
  • Tremblay-Mercier J, Madjar C, Das S, Pichet Binette A, Dyke SOM, Étienne P, PREVENT-AD Research Group, et al. Open science datasets from PREVENT-AD, a longitudinal cohort of pre-symptomatic Alzheimer's disease. Neuroimage Clin. 2021;31:102733.
  • Das S, Zijdenbos AP, Harlap J, Vins D, Evans AC. LORIS: a web-based data management system for multi-center studies. Front Neuroinform. 2011;5:37.
  • Van Rheenen W, Pulit SL, Dekker AM, Al Khleifat A, Brands WJ, Iacoangeli A, et al. Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis. Eur J Hum Genet. 2018.
  • Steinbach R, Gaur N, Stubendorff B, Witte OW, Grosskreutz J. Developing a neuroimaging biomarker for amyotrophic lateral sclerosis: multi-center data sharing and the road to a “global cohort.” Front Neurol 2018. Dec 4;9:1055
  • Turner MR, Grosskreutz J, Kassubek J, Abrahams S, Agosta F, Benatar M, et al. Towards a neuroimaging biomarker for amyotrophic lateral sclerosis. Lancet Neurol. 2011;10:400–3.
  • Müller HP, Turner MR, Grosskreutz J, Abrahams S, Bede P, Govind V, et al. A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2016;87:570–9.
  • Farhan SMK, Bartha R, Black SE, Corbett D, Finger E, Freedman M, et al. The Ontario Neurodegenerative Disease Research Initiative (ONDRI). Can J Neurol Sci 2017. Mar;44(2):196-202.
  • Ramirez J, Holmes MF, Scott CJM, Ozzoude M, Adamo S, Szilagyi GM, et al. Ontario Neurodegenerative Disease Research Initiative (ONDRI): structural MRI methods and outcome measures. Front Neurol 2020. Aug 11;11:847
  • McLaughlin PM, Sunderland KM, Beaton D, Binns MA, Kwan D, Levine B, et al. The quality assurance and quality control protocol for neuropsychological data collection and curation in the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study. Assessment 2021;28:1267–86.
  • Kapoor A, Bartha R, Black SE, Borrie M, Freedman M, Gao F, et al. Structural brain magnetic resonance imaging to rule out comorbid pathology in the assessment of Alzheimer’s disease dementia: findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and clinical trials over the past 10 years. J Alzheimer’s Dis 2020;74(3):747–757.